U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8154181541The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small VesselsActive, not recruitingHas ResultsCoronary Artery DiseaseDevice: PROMUS Element Coronary Stent Systemhttps://ClinicalTrials.gov/show/NCT01498692
8154281542Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.CompletedHas ResultsAsthmaDrug: GW685698/GW642444 (fluticasone furoate/vilanterol trifenatate)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01498679
8154381543Efficacy of Lactobacillus Reuteri Protectis on Functional Abdominal Pain (FAP) in Children 8-14 Years OldTerminatedNo Results AvailableAbdominal PainDietary Supplement: L. reuteri protectis|Dietary Supplement: Placebo tablethttps://ClinicalTrials.gov/show/NCT01498666
8154481544Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian AncestryCompletedHas ResultsAsthmaDrug: GW685698/GW642444|Drug: CCI18781https://ClinicalTrials.gov/show/NCT01498653
8154581545Retreatment of Recurrent Dupuytren's ContracturesCompletedHas ResultsDupuytren's DiseaseBiological: Collagenase clostridium histolyticumhttps://ClinicalTrials.gov/show/NCT01498640
8154681546Cervarix Long-term Safety SurveillanceCompletedNo Results AvailableInfections, PapillomavirusBiological: Cervarix|Other: Data collectionhttps://ClinicalTrials.gov/show/NCT01498627
8154781547Psychological Impact in Diabetes: Intervention With Affect School and Basal Body AwarenessActive, not recruitingNo Results AvailableDiabetes Mellitus|Depression|Alexithymia|AnxietyBehavioral: Affect School and Basal body awarenesshttps://ClinicalTrials.gov/show/NCT01498614
8154881548Improving Oral Care to Reduce Hospital-Acquired Pneumonia (HAP) in the Acute Neurologically Impaired AdultCompletedHas ResultsPneumoniaOther: Enhanced oral care protocolhttps://ClinicalTrials.gov/show/NCT01498601
8154981549Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast CancerActive, not recruitingNo Results AvailableBreast Neoplasms|Breast Cancer|Breast Tumors|Cancer of the Breast|Neoplasms, Breast|Tumors, BreastDrug: Eribulin|Drug: Doxorubicin|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT01498588
8155081550An Evaluation of a Web-based Intervention Program for Parents and Teens to Promote Safe DrivingCompletedHas ResultsNovice Teen Driver TrainingBehavioral: Teen driving planhttps://ClinicalTrials.gov/show/NCT01498575
8155181551Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung CancerCompletedNo Results AvailableNon Small Cell Lung Cancer (NSCLC)Drug: Gefitinib and Nimotuzumab|Drug: Gefitinibhttps://ClinicalTrials.gov/show/NCT01498562
8155281552Cognitive Effects of Atomoxetine in Humans: Genetic ModeratorsCompletedNo Results AvailableAddictionDrug: Atomoxetine|Drug: Sugar Pillhttps://ClinicalTrials.gov/show/NCT01498549
8155381553Effect of Diet and Exercise in Breast Cancer SurvivorsCompletedNo Results AvailableBreast Cancer|ObesityBehavioral: aerobic exercisehttps://ClinicalTrials.gov/show/NCT01498536
8155481554The Glycaemic and Insulinaemic Responses of Camel MilkCompletedNo Results AvailableHealthyOther: Camel milk|Other: camel milk powder solution|Other: raw cow milk|Other: Glucose solutionhttps://ClinicalTrials.gov/show/NCT01498523
8155581555Web-based Cognitive-behavior Therapy (CBT) for Opioid-treated, Chronic Pain Patients With Aberrant BehaviorActive, not recruitingNo Results AvailableChronic PainBehavioral: Therapeutic Education System (TES) for chronic painhttps://ClinicalTrials.gov/show/NCT01498510
8155681556A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021Enrolling by invitationNo Results AvailableEosinophilic EsophagitisDrug: EUR-1100|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01498497
8155781557Therapeutic Effects Of Epstein-Barr Virus Immune T-Lymphocytes Derived From A Normal HLA- Compatible Or Partially- Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated MalignanciesRecruitingNo Results AvailableNon-Hodgkin's Lymphoma|Epstein-Barr VirusBiological: EBV-specific T-cells|Biological: EBV-specific T-cellshttps://ClinicalTrials.gov/show/NCT01498484
8155881558NICE Guideline 'Red Flags' to Predict Serious Outcome After Transient Loss of ConsciousnessNot yet recruitingNo Results AvailableSyncopehttps://ClinicalTrials.gov/show/NCT01498471
8155981559Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast CancerCompletedHas ResultsMetastatic Breast CancerDrug: Pazopanib plus capecitabinehttps://ClinicalTrials.gov/show/NCT01498458
8156081560An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357)RecruitingNo Results AvailableLeukemiaDrug: Dasatinib|Drug: Decitabine|Drug: Decitabinehttps://ClinicalTrials.gov/show/NCT01498445
8156181561Physiological Response to Heliox21 and Air O2Not yet recruitingNo Results AvailableRespiratory InsufficiencyDrug: Heliox21|Drug: Air O2https://ClinicalTrials.gov/show/NCT01498432
8156281562Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB)Active, not recruitingNo Results AvailablePulmonary TuberculosisDrug: Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg)|Drug: Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg)|Drug: Drug Sensitive: Rifafour|Drug: Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg)https://ClinicalTrials.gov/show/NCT01498419
8156381563Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous LupusTerminatedNo Results AvailableCutaneous Lupus ErythematosusDietary Supplement: vitamin Dhttps://ClinicalTrials.gov/show/NCT01498406
81564815641320 nm Nd:YAG Laser for Improving the Appearance of OnychomycosisCompletedNo Results AvailableFungal Nail InfectionDevice: Laser treatmenthttps://ClinicalTrials.gov/show/NCT01498393
8156581565The Bolus Dose of Dexmedetomidine (ED50) That Avoids Hemodynamic Compromise in ChildrenCompletedNo Results AvailableHemodynamic InstabilityDrug: Dexmedetomidinehttps://ClinicalTrials.gov/show/NCT01498380
8156681566Life-long Tele-monitoring of Patients With Type 2 Diabetes Mellitus in Central GreeceCompletedNo Results AvailableDiabetes Mellitus, Type 2Procedure: Telemonitoring of patients with diabetes type 2https://ClinicalTrials.gov/show/NCT01498367
8156781567Efficiency of Two Dimensional High Definition Versus Three Dimensional Endoscopic Systems in Transanal Endoscopic SurgeryCompletedNo Results AvailableRectal Adenomas and Adenocarcinomas "in Situ"Procedure: 2-D high definition vision systems, transanal endoscopic operation (TEO)|Procedure: Transanal endoscopic microsurgery (TEM)https://ClinicalTrials.gov/show/NCT01498354
8156881568Hypoparathyroidism in DenmarkCompletedNo Results AvailableHypoparathyroidismhttps://ClinicalTrials.gov/show/NCT01498341
8156981569A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive GlioblastomaActive, not recruitingNo Results AvailableGlioblastoma|Small Cell Glioblastoma|Giant Cell Glioblastoma|Gliosarcoma|Glioblastoma With Oligodendroglial Component|Recurrent Glioblastoma|Relapsed GlioblastomaDrug: Bevacizumab|Drug: Rindopepimut (CDX-110) with GM-CSF|Drug: KLHhttps://ClinicalTrials.gov/show/NCT01498328
8157081570The Incidence of Pelvic Hematoma Following HysterectomyCompletedNo Results AvailableHematomaOther: Ultrasound examinationhttps://ClinicalTrials.gov/show/NCT01498315

* Görseller ve İçerik tekif hakkına sahip olabilir